Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?

Thromb Res. 2021 Dec:208:170-172. doi: 10.1016/j.thromres.2021.11.008. Epub 2021 Nov 16.
No abstract available

Keywords: COVID-19; IL-6 antagonists; Venous thromboembolism.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Interleukin-6
  • SARS-CoV-2
  • Venous Thromboembolism* / drug therapy
  • Venous Thrombosis*

Substances

  • Interleukin-6